Pharmacists challenge DUR program of OTC drugs

Published: 2011-08-25 06:57:00

Updated: 2011-08-25 06:57:00

A dispute has arisen over the planned introduction next month of a government-imposed review of over-the-counter (OTC) medicines.

The Korean Pharmaceutical Association said yesterday it will boycott the Drug Utilization Review (DUR) system, claiming it will be meaningless to join the program a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK